H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival

H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall Survival

<i>Background</i>: H2AX can be of prognostic value in breast cancer, since in advanced stage patients with high levels, there was an association with worse overall survival (OS). However, the clinical relevance of H2AX in ovarian cancer (OC) remains to be elucidated. <i>Methods<...

Full description

Bibliographic Details
Main Authors: Sayeh Saravi, Eriko Katsuta, Jeyarooban Jeyaneethi, Hasnat A. Amin, Matthias Kaspar, Kazuaki Takabe, George Pados, Fotios Drenos, Marcia Hall, Emmanouil Karteris
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
H2AX
ovarian cancer
biomarker
polymorphisms
Online Access:https://www.mdpi.com/2077-0383/9/9/2844

Internet

https://www.mdpi.com/2077-0383/9/9/2844

Similar Items